These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22615645)

  • 1. Evaluation of the use of partition coefficients and molecular surface properties as predictors of drug absorption: a provisional biopharmaceutical classification of the list of national essential medicines of Pakistan.
    Shawahna R; Rahman N
    Daru; 2011; 19(2):83-99. PubMed ID: 22615645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification.
    Kasim NA; Whitehouse M; Ramachandran C; Bermejo M; Lennernäs H; Hussain AS; Junginger HE; Stavchansky SA; Midha KK; Shah VP; Amidon GL
    Mol Pharm; 2004 Jan; 1(1):85-96. PubMed ID: 15832504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan.
    Takagi T; Ramachandran C; Bermejo M; Yamashita S; Yu LX; Amidon GL
    Mol Pharm; 2006; 3(6):631-43. PubMed ID: 17140251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The low/high BCS permeability class boundary: physicochemical comparison of metoprolol and labetalol.
    Zur M; Gasparini M; Wolk O; Amidon GL; Dahan A
    Mol Pharm; 2014 May; 11(5):1707-14. PubMed ID: 24735251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Provisional classification and in silico study of biopharmaceutical system based on caco-2 cell permeability and dose number.
    Pham-The H; Garrigues T; Bermejo M; González-Álvarez I; Monteagudo MC; Cabrera-Pérez MÁ
    Mol Pharm; 2013 Jun; 10(6):2445-61. PubMed ID: 23675957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biopharmaceutical optimization in neglected diseases for paediatric patients by applying the provisional paediatric biopharmaceutical classification system.
    Del Moral Sanchez JM; Gonzalez-Alvarez I; Cerda-Revert A; Gonzalez-Alvarez M; Navarro-Ruiz A; Amidon GL; Bermejo M
    Br J Clin Pharmacol; 2018 Oct; 84(10):2231-2241. PubMed ID: 29846973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purely in silico BCS classification: science based quality standards for the world's drugs.
    Dahan A; Wolk O; Kim YH; Ramachandran C; Crippen GM; Takagi T; Bermejo M; Amidon GL
    Mol Pharm; 2013 Nov; 10(11):4378-90. PubMed ID: 24094040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating theoretical and experimental permeability estimations for provisional biopharmaceutical classification: Application to the WHO essential medicines.
    Cabrera-Pérez MÁ; Pham-The H; Cervera MF; Hernández-Armengol R; Miranda-Pérez de Alejo C; Brito-Ferrer Y
    Biopharm Drug Dispos; 2018 Jul; 39(7):354-368. PubMed ID: 30021059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing the pharmaceutical quality of Chinese herbal medicine: a provisional BCS classification.
    Fong SY; Liu M; Wei H; Löbenberg R; Kanfer I; Lee VH; Amidon GL; Zuo Z
    Mol Pharm; 2013 May; 10(5):1623-43. PubMed ID: 23473440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biopharmaceutics of successful controlled release drug product: Segmental-dependent permeability of glipizide vs. metoprolol throughout the intestinal tract.
    Zur M; Cohen N; Agbaria R; Dahan A
    Int J Pharm; 2015 Jul; 489(1-2):304-10. PubMed ID: 25957705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCS Class IV Oral Drugs and Absorption Windows: Regional-Dependent Intestinal Permeability of Furosemide.
    Markovic M; Zur M; Ragatsky I; Cvijić S; Dahan A
    Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33276565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption classification of oral drugs based on molecular surface properties.
    Bergström CA; Strafford M; Lazorova L; Avdeef A; Luthman K; Artursson P
    J Med Chem; 2003 Feb; 46(4):558-70. PubMed ID: 12570377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The "high solubility" definition of the current FDA Guidance on Biopharmaceutical Classification System may be too strict for acidic drugs.
    Yazdanian M; Briggs K; Jankovsky C; Hawi A
    Pharm Res; 2004 Feb; 21(2):293-9. PubMed ID: 15032311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system.
    Lindenberg M; Kopp S; Dressman JB
    Eur J Pharm Biopharm; 2004 Sep; 58(2):265-78. PubMed ID: 15296954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-permeability criterion for BCS classification: segmental/pH dependent permeability considerations.
    Dahan A; Miller JM; Hilfinger JM; Yamashita S; Yu LX; Lennernäs H; Amidon GL
    Mol Pharm; 2010 Oct; 7(5):1827-34. PubMed ID: 20701326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding
    B Shekhawat P; B Pokharkar V
    Acta Pharm Sin B; 2017 May; 7(3):260-280. PubMed ID: 28540164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of five active ingredients of Er-Zhi-Wan, a traditional Chinese medicine water-honeyed pill, using the biopharmaceutics classification system.
    Cao X; Li H; Wang M; Ren X; Deng Y
    Biomed Chromatogr; 2020 Feb; 34(2):e4757. PubMed ID: 31755125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complexity of intestinal permeability: Assigning the correct BCS classification through careful data interpretation.
    Zur M; Hanson AS; Dahan A
    Eur J Pharm Sci; 2014 Sep; 61():11-7. PubMed ID: 24262076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Segmental-Dependent Solubility and Permeability as Key Factors Guiding Controlled Release Drug Product Development.
    Markovic M; Zur M; Fine-Shamir N; Haimov E; González-Álvarez I; Dahan A
    Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32214015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.